Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Neuromuscular Disorders : NMD|July 28, 2016
Commonality amid diversity: Multi-study proteomic identification of conserved disease mechanisms in spinal muscular atrophyHeidi R Fuller, Thomas H Gillingwater, Thomas M Wishart
Journal of Neuropathology and Experimental Neurology|August 10, 2006
Synaptic vulnerability in neurodegenerative diseaseThomas M Wishart, Simon H Parson, Thomas H Gillingwater
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 18, 2019
Applying modern Omic technologies to the Neuronal Ceroid LipofuscinosesRachel A Kline, Thomas M Wishart, Kevin Mills, et al.
Plos One|December 3, 2010
Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-doseAnn K Wright, Thomas M Wishart, Cali A Ingham, et al.
Expert Review of Proteomics|June 23, 2016
Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentationHeidi R Fuller, Laura C Graham, Maica Llavero Hurtado, et al.
Journal of Anatomy|December 3, 2011
Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?Sophie R Thomson, Thomas M Wishart, Rickie Patani, et al.
Genome Medicine|October 19, 2013
Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophyChantal A Mutsaers, Douglas J Lamont, Gillian Hunter, et al.
Brain Communications|August 16, 2021
Microarray profiling emphasizes transcriptomic differences between hippocampal in vivo tissue and in vitro culturesDeclan King, Paul A Skehel, Owen Dando, et al.
Pageof 8